Survival of human immunodeficiency virus-infected patients on maintenance dialysis. NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Survival of human immunodeficiency virus-infected patients on maintenance dialysis.

Clin Nephrol. 1989 Nov;32(5):221-4. Unique Identifier : AIDSLINE MED/90058971
Feinfeld DA; Kaplan R; Dressler R; Lynn RI; Baumritter Kidney Center, Albert Einstein College of Medicine,; Bronx, New York 10583.

Abstract: It has recently been reported that patients on maintenance dialysis with the acquired immune deficiency syndrome (AIDS) survive only 1 to 3 months. We studied all patients on maintenance dialysis at the Baumritter Kidney Center who were known to be infected with the human immunodeficiency virus (HIV). Five patients met the criteria for AIDS; another ten had anti-HIV antibodies but no opportunistic infections. The AIDS patients survived 8 to 18 months, and two are still alive. Mean survival in the AIDS group was 13.2 +/- 1.9 months, while the HIV(+) non-AIDS group survived 15.7 +/- 3.0 months. While these data are not statistically different, the survival curve in the AIDS group predicted a shorter survival than for the HIV(+) patients without AIDS. In fact, the survival of our dialyzed AIDS patients was similar to that reported for AIDS patients in general. Our experience suggests that dialysis may have no adverse effect on survival in AIDS. We conclude that dialysis patients with AIDS may survive 8 to 12 months or more and that the approach to such patients should be individualized.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/*MORTALITY/ THERAPY Actuarial Analysis Comparative Study Evaluation Studies Female Hemodialysis/*MORTALITY Human HIV Seropositivity/MORTALITY/THERAPY Life Expectancy Male Opportunistic Infections/ETIOLOGY Retrospective Studies JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/complications/KWDmortality/therapyactuarialanalysiscomparativestudyevaluationstudiesfemalehemodialysis/KWDmortalityhumanhivseropositivity/mortality/therapylifeexpectancymaleopportunisticinfections/etiologyretrospectivestudiesjournalarticle
900330
M9030666

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .